Genome-wide Transcriptional Analysis of Differentially Expressed Genes in Diabetic, Healing Corneal Epithelial Cells: Hyperglycemia-suppressed TGFβ3 Expression Contributes to the Delay of Epithelial Wound Healing in Diabetic Corneas
Overview
Affiliations
Patients with diabetes mellitus (DM) may develop corneal complications and delayed wound healing. The aims of this study are to characterize the molecular signatures and biological pathways leading to delayed epithelial wound healing and to delineate the involvement of TGFβ3 therein. Genome-wide cDNA microarray analysis revealed 1,888 differentially expressed genes in the healing epithelia of normal (NL) versus type 1 DM rat corneas. Gene ontology and enrichment analyses indicated TGFβ signaling as a major altered pathway. Among three TGFβ isoforms, TGF-β1 and β3 were upregulated in response to wounding in NL corneal epithelial cells (CECs), whereas the latter was greatly suppressed by hyperglycemia in rat type 1 and 2 and mouse type 1 DM models. Functional analysis indicated that TGF-β3 contributed to wound healing in NL corneas. Moreover, exogenously added TGF-β3 accelerated epithelial wound closure in type 2 rat and type 1 mouse DM corneas via Smad and PI3K-AKT signaling pathways, autoregulation, and/or upregulation of Serpine1, a well-known TGFβ target gene. Taken together, our study for the first time provides a comprehensive list of genes differentially expressed in the healing CECs of NL versus diabetic corneas and suggests the therapeutic potential of TGF-β3 for treating corneal and skin wounds in diabetic patients.
Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways.
Diaz D, Sassani J, Zagon I, McLaughlin P Invest Ophthalmol Vis Sci. 2025; 66(3):24.
PMID: 40062813 PMC: 11905607. DOI: 10.1167/iovs.66.3.24.
Therapeutic benefits of glycerol in dry eye disease.
Ronderos V, Bollag W Front Med (Lausanne). 2025; 11:1531670.
PMID: 39882517 PMC: 11774691. DOI: 10.3389/fmed.2024.1531670.
Corneal injury repair and the potential involvement of ZEB1.
Jin L, Zhang L, Yan C, Liu M, Dean D, Liu Y Eye Vis (Lond). 2024; 11(1):20.
PMID: 38822380 PMC: 11143703. DOI: 10.1186/s40662-024-00387-0.
Gong J, Ding G, Hao Z, Li Y, Deng A, Zhang C Front Med (Lausanne). 2024; 11:1384500.
PMID: 38638937 PMC: 11024251. DOI: 10.3389/fmed.2024.1384500.
Gao N, Yu F Invest Ophthalmol Vis Sci. 2024; 65(3):35.
PMID: 38546583 PMC: 10981440. DOI: 10.1167/iovs.65.3.35.